Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer.
The goal of this study was to evaluate the feasibility, reliability, and validity of a computer-based geriatric assessment via two methods of electronic data capture ( SupportScreen and REDCap) compared with paper-and-pencil data capture among older adults with cancer.



Eligible patients were ≥ 65 years old, had a cancer diagnosis, and were fluent in English. Patients were randomly assigned to one of four arms, in which they completed the geriatric assessment twice: (1) REDCap and paper and pencil in sessions 1 and 2; (2) REDCap in both sessions; (3) SupportScreen and paper and pencil in sessions 1 and 2; and (4) SupportScreen in both sessions. The feasibility, reliability, and validity of the computer-based geriatric assessment compared with paper and pencil were evaluated.



The median age of participants (N = 100) was 71 years (range, 65 to 91 years) and the diagnosis was solid tumor (82%) or hematologic malignancy (18%). For session 1, REDCap took significantly longer to complete than paper and pencil (median, 21 minutes [range, 11 to 44 minutes] v median, 15 minutes [range, 9 to 29 minutes], P < .01) or SupportScreen (median, 16 minutes [range, 6 to 38 minutes], P < .01). There were no significant differences in completion times between SupportScreen and paper and pencil ( P = .50). The computer-based geriatric assessment was feasible. Few participants (8%) needed help with completing the geriatric assessment (REDCap, n = 7 and SupportScreen, n = 1), 89% reported that the length was "just right," and 67% preferred the computer-based geriatric assessment to paper and pencil. Test-retest reliability was high (Spearman correlation coefficient ≥ 0.79) for all scales except for social activity. Validity among similar scales was demonstrated.



Delivering a computer-based geriatric assessment is feasible, reliable, and valid. SupportScreen methodology is preferred to REDCap.
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Arti
A
Hurria
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Chie
C
Akiba
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Jerome
J
Kim
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Dale
D
Mitani
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Matthew
M
Loscalzo
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Vani
V
Katheria
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Marianna
M
Koczywas
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Sumanta
S
Pal
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Vincent
V
Chung
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Stephen
S
Forman
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Nitya
N
Nathwani
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Marwan
M
Fakih
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Chatchada
C
Karanes
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Dean
D
Lim
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Leslie
L
Popplewell
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Harvey
H
Cohen
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Beverly
B
Canin
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
David
D
Cella
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Betty
B
Ferrell
City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA; Duke University Medical Center, Durham, NC; Breast Cancer Advocate, New York, NY; and Northwestern University Feinberg School of Medicine, Chicago, IL.
Leanne
L
Goldstein
D000368:Aged; D000369:Aged, 80 and over; D005240:Feasibility Studies; D005260:Female; D015577:Geriatric Assessment / Q000379:methods*; D006801:Humans; D008297:Male; D009369:Neoplasms; D015203:Reproducibility of Results; D011795:Surveys and Questionnaires